Toggle Menu
Join our Community
Support ToI and remove
all
ads
Learn more
English
Français
עברית
Get The Daily Edition
Account
Sign In
Sign in
Join our Community
Open Search form
Toggle Menu
Israel & the Region
Jewish Times
Israel Inside
Tech Israel
Real Estate
Israel
The Blogs
Podcasts
Video
Newsletters
The Daily Edition
What Matters Most Today
Tech Israel
Updates from Silicon Wadi
Real Estate Israel
Monthly Update
The Weekend Edition
The Best Reads of the Week
Weekly Highlights
Choice Voices From The Blogs
Partners
Atlanta
Atlanta Jewish Times
North New Jersey
The Jewish Standard
Pittsburgh
Jewish Chronicle
United Kingdom
The Jewish News
Australia
The Australian Jewish News
For Publishers
Become a Partner
Open Search form
Toggle Menu
search
Input search
Clear search input
English
Français
עברית
Latest Articles
Latest Alerts
Israel & the Region
Jewish Times
Israel Inside
Tech Israel
Real Estate
Israel
The Blogs
Podcasts
Video
Newsletters
The Daily Edition
What Matters Most Today
Tech Israel
Updates from Silicon Wadi
Real Estate Israel
Monthly Update
The Weekend Edition
The Best Reads of the Week
Weekly Highlights
Choice Voices From The Blogs
Partners
Atlanta
Atlanta Jewish Times
North New Jersey
The Jewish Standard
Pittsburgh
Jewish Chronicle
United Kingdom
The Jewish News
Australia
The Australian Jewish News
For Publishers
Become a Partner
Community
Join our community
Sign in
About The Times of Israel
Advertise on The Times of Israel
Contact us
Download our App
For IOS users
For Android users
Get the Daily Edition
submit
Follow us
© 2026 The Times of Israel , All Rights Reserved
Terms and conditions
Privacy policy
Input search
Clear search input
×
Multiple Sclerosis
Advertisement
September 10, 2024, 9:50 pm
Teva faces European Union antitrust fine over shenanigans to thwart rivals
Pharmaceutical giant accused of disparaging competitor’s multiple sclerosis medicine and misusing patent system to shield own Copaxone product
By
Reuters
and
ToI Staff
August 8, 2023, 8:16 pm
Created from stem cells, Israeli researchers grow tiny, beating model of human heart
The size of a third of a grain of rice, organoid connected to sensors reveals previously unknown aspects of cardiac physiology
By
Renee Ghert-Zand
March 1, 2022, 2:39 pm
Israeli study: Stem cells may help multiple sclerosis brain ‘repair itself’
Eight of 15 patients who receive NG-01 therapy as spinal injection see better disability scores; inventors say therapy may ‘dramatically improve’ patients’ lives
By
Nathan Jeffay
January 15, 2022, 6:54 pm
New study finds ‘kissing disease’ virus is leading cause of multiple sclerosis
Harvard researcher says developing a vaccine or treatment for Epstein-Barr infection ‘could ultimately prevent or cure MS’
By
AFP
December 10, 2020, 5:49 am
Stem cell treatment ‘freezes’ MS, lets some walk again, Jerusalem study finds
Small study saw improvement in 73% of multiple sclerosis patients who got spinal injection containing treatment made from their own cells; larger trials now planned
By
Nathan Jeffay
June 23, 2020, 3:19 pm
Nano-engineered pomegranate oil holds hope for brain disease, study shows
30 multiple sclerosis patients in Jerusalem who took antioxidant-rich food supplement for 3 months saw ‘significant cognitive improvement’
By
Shoshanna Solomon
August 19, 2019, 8:00 pm
Israeli-American basketball coach Blatt reveals he has MS
Ex-NBA coach says he has adopted strict exercise regimen to prevent muscle deterioration, vows to continue helming Greek team Olympiacos
By
ToI Staff
April 30, 2019, 9:44 am
Israeli researchers discover MS drug could help epilepsy patients
Breakthrough may lead to new drugs for the 30%-40% of epilepsy sufferers who don’t respond to existing treatments
By
ToI Staff
October 18, 2018, 1:15 pm
Environmental factors can trigger onset of multiple sclerosis — Israeli study
Elevated salt concentrations and temperature may lead to harmful structural changes in protective neural membranes, Tel Aviv University researchers say
By
Shoshanna Solomon
April 11, 2018, 12:19 am
Mylan buys rights to Israel-developed Multiple Sclerosis treatment
MS drug developed by Mapi Pharma requires a once-monthly injection instead of 3 times a week
By
ToI Staff
January 12, 2018, 7:23 pm
Senior sex and quirky bromance in MD’s debut film — Martin Landau’s last hurrah
The Jewish actor’s stunning final performance in ‘Abe & Phil’s Last Poker Game’ is only outdone by the movie’s writer: a 73-year-old Harvard neurologist
By
Renee Ghert-Zand
May 23, 2016, 3:41 pm
ReWalk tech to help stroke, MS victims get moving
Israeli-developed exoskeleton technology will be applied to help millions who can’t walk by themselves but are not paralyzed
By
ToI Staff
March 15, 2016, 4:10 am
Israeli-developed blood test may be able to identify diseases
DNA strands in the blood can reveal which cells in a body may be dying, alerting physicians early on, Hebrew University researchers say
By
AFP
September 8, 2015, 11:00 am
Unique center uses music to treat multiple sclerosis
The Grabski Center’s therapy program helps the wheelchair bound ‘sing their song’
By
Luke Tress
Load More
Advertisement
close popup
Sign in or Join The Times of Israel Community
Paying ToI Community members are invited to comment on articles
Email address
*
Please use the following structure: example@domain.com
Continue
Or Continue with
By joining you agree to the
terms and conditions
back
close popup
Register to continue
Email address
*
Change
REGISTER
Or Continue with
back
close popup
Log in to continue
Email address
*
Something went wrong.
Please try again in a few minutes..
Continue
back
close popup
Sign in or Join The Times of Israel Community
You are currently registered. Please join The Times of Israel Community to comment and enjoy other Community benefits
Only ToI Community members can comment below articles
Email address
*
Password
*
Incorrect password. Please try again or choose an option below.
Forgot your password?
/
Send me a login link
Continue
Sign in without joining
Or Continue with
close popup
Check your email
We sent an email to you at
.
It has a link that will sign you in.
Click the link in that email to complete registration so you can comment.
back
close popup
Join The Times of Israel Community
Commenting is available for paying members of The Times of Israel Community only. Please join our Community to comment and enjoy other Community benefits.
Email address
*
Please use the following structure: example@domain.com
JOIN NOW!
close popup
Thank you! Now check your email
You are now a member of The Times of Israel Community! We sent you an email with a login link to
. Once you're set up, you can start enjoying Community benefits and commenting.
Back to top
Never miss breaking news on Israel
Get notifications to stay updated
Stay updated
No thanks
You're subscribed
close popup
Register for free
and continue reading
Registering allows you to manage your newsletters and alerts and helps us improve your experience. It takes just a few seconds.
Already registered? Enter your email to sign in.
Email address
Please use the following structure: example@domain.com
REGISTER OR SIGN IN
Or Continue with
By registering you agree to the
terms and conditions
. Once registered, you’ll receive our Daily Edition email for free.
Send me The Times of Israel Daily Edition
back
close popup
Register to continue
Email address
Change
REGISTER
Or Continue with
back
close popup
Log in to continue
Email address
Something went wrong.
Please try again in a few minutes..
Continue
back
close popup
Sign in or Register
Email address
*
Password
*
Incorrect password. Please try again or choose an option below.
Continue
I forgot my password
/
Send me a sign in link
Or Continue with
back
close popup
Check your email
We sent an email to you at
.
It has a link that will sign you in.
Click the link in that email to complete your registration.